Citizen, Fossil develop wristwatch able to receive data

Citizen, Fossil develop wristwatch able to receive data

TOKYO, Japan - Citizen Watch Co. and U.S. watchmaker Fossil Inc. have started production of Wrist Net (shown) -- a wristwatch jointly developed by the two companies for the North American market and capable of receiving news, weather and other information, the Japanese watchmaker said Jan. 21.

  • Product Code
  • ILEA001100912
  • Registered date
  • 2004/1/21 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2004 Kyodo News
  • Media size
  • 1864 × 1228 pixel
  • Resolution
  • dpi
  • Deployment size
  • 230.72(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    JR Kyushu and SkyDrive tie up in flying taxi business

    JR Kyushu and SkyDrive tie up in flying taxi business

    SkyDrive Inc. CEO Tomohiro Fukuzawa (R) and Kyushu Railway Co. President Yoji Furumiya shake hands in Tokyo on July 4, 2024, after the two companies concluded a business partnership accord to study the feasibility of commercializing a flying taxi service at railway stations operated by the JR company on the southwestern Japan main island of Kyushu and commercial facilities in the Kyushu region in 2026 at the earliest.
      Watchdog accuses bank of sharing info with brokerage affiliates

      Watchdog accuses bank of sharing info with brokerage affiliates

      Photo taken on June 7, 2024, shows Mitsubishi UFJ Financial Group Inc.'s headquarters in Tokyo. Japan's securities watchdog is expected to call for the Financial Services Agency to punish a bank and two brokerage firms operating under the group over allegations they shared confidential information about client companies without obtaining permission.

        Sompo CEO to step down over Bigmotor insurance fraud scandal

        TOKYO, Japan, Jan. 26 Kyodo - Major Japanese insurance firm Sompo Holdings Inc. CEO Kengo Sakurada holds a press conference in Tokyo on Jan. 26, 2024, to announce he will step down at the end of March to take responsibility for the company's involvement in used car dealer Bigmotor Co.'s insurance fraud scandal. (Kyodo)
          Press conference by Japan's SBI, Taiwan's PSMC

          Press conference by Japan's SBI, Taiwan's PSMC

          Yoshitaka Kitao (L), chairman and president of Japanese financial group SBI Holdings Inc., and Frank Huang, chairman of Taiwan's Powerchip Semiconductor Manufacturing Corp., attend a press conference in Tokyo on Oct. 31, 2023. The two companies said they have selected the village of Ohira in Miyagi Prefecture, northeastern Japan, as the location for their planned joint chip factory.
            Press conference by Japan's SBI, Taiwan's PSMC

            Press conference by Japan's SBI, Taiwan's PSMC

            Yoshitaka Kitao (L), chairman and president of Japanese financial group SBI Holdings Inc., and Frank Huang, chairman of Taiwan's Powerchip Semiconductor Manufacturing Corp., shake hands at a press conference in Tokyo on Oct. 31, 2023. The two companies said they have selected the village of Ohira in Miyagi Prefecture, northeastern Japan, as the location for their planned joint chip factory.
              U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

              U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

              Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                    EV maker BYD's entry into Japan market

                    EV maker BYD's entry into Japan market

                    The Japanese unit of Chinese electric vehicle maker BYD Co. holds a press event in Tokyo on July 21, 2022, to announce its entry into the Japanese vehicle market.
                      Joint Conference by SOMPO Holdings and Palantir Technologies

                      Joint Conference by SOMPO Holdings and Palantir Technologies

                      Palantir Technologies (California) , a U.S. provider of big data analysis, announced on the 18th that it has established a joint venture with SOMPO Holdings (HD) (photo). On December 1, Palantir will provide a service to analyze all kinds of data within Japanese companies and public institutions, including Excel, e-mail, and call records. The data will be used to predict the possibility of free recalls of automobile parts and to detect money laundering. The new company, Palantir Technologies Japan (Chuo Ward, Tokyo), is 50% owned by Palantir and 50% by SOMPOHD. It will be capitalized at 100 million dollars (about 10.8 billion yen), and aims to achieve sales of 100 billion yen in the medium to long term. President Kengo Sakurada expressed his hope that the company will pursue its dream of becoming a real data platformer. Photo taken on November 18, 2019, credit: Nikkan Kogyo Shimbun / Kyodo News Images